HRD-NEGATIVE EPITHELIAL OVARIAN CANCER

Clinical trials for HRD-NEGATIVE EPITHELIAL OVARIAN CANCER explained in plain language.

Never miss a new study

Get alerted when new HRD-NEGATIVE EPITHELIAL OVARIAN CANCER trials appear

Sign up with your email to follow new studies for HRD-NEGATIVE EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Scientists test Custom-Made immune cells to fight tough ovarian cancer

Disease control Not yet recruiting

This early study is testing a new, personalized treatment for a specific type of ovarian cancer that has not responded well to standard therapy. Doctors will take a patient's own immune cells, train them to recognize the patient's unique cancer markers, and then inject them back.…

Matched conditions: HRD-NEGATIVE EPITHELIAL OVARIAN CANCER

Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

HRD-NEGATIVE EPITHELIAL OVARIAN CANCER

Get alerted when new HRD-NEGATIVE EPITHELIAL OVARIAN CANCER trials appear

Scientists test Custom-Made immune cells to fight tough ovarian cancer